Resources

CLINICAL EVIDENCE

0

Freedom From CD-TLR
at 6-Months

0

Average Recoil vs
55% with POBA

0

Bailout Stent Rate

Read Peer Reviewed Studies

  • PRELUDE Study

    Prospective, core-lab adjudicated

  • PRELUDE-BTK Study

    Prospective, core-lab adjudicated

  • Recoil Study

    Multi-center, core-lab adjudicated

  • Serranator Vs POBA

    Single-Center Subanalysis From the PRELUDE-BTK Prospective Study

  • Pedal Study

    Multi-center, core-lab adjudicated, retrospective study

Clinical Data Overview

The Serranator has been studied in both the above-the-knee and below-the-knee anatomy. Our clinical trials were prospective, core-lab adjudicated, 100% data monitored studies that were published in peer-reviewed journals.

Ready to Learn More?